Global Teriflunomide Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator.
According to our (Global Info Research) latest study, the global Teriflunomide market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Teriflunomide market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Teriflunomide market size and forecasts, in consumption value ($ Million), 2018-2029
Global Teriflunomide market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Teriflunomide market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Teriflunomide market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Teriflunomide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Teriflunomide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Aventis, Genzyme Corporation, Amneal Pharmaceuticals NY LC, Glenmark Pharmaceuticals and Msn Laboratories Private Limited. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Teriflunomide market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Teriflunomide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Teriflunomide, with revenue, gross margin and global market share of Teriflunomide from 2018 to 2023.
Chapter 3, the Teriflunomide competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Teriflunomide market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Teriflunomide.
Chapter 13, to describe Teriflunomide research findings and conclusion.
According to our (Global Info Research) latest study, the global Teriflunomide market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Teriflunomide market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Teriflunomide market size and forecasts, in consumption value ($ Million), 2018-2029
Global Teriflunomide market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Teriflunomide market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Teriflunomide market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Teriflunomide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Teriflunomide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Aventis, Genzyme Corporation, Amneal Pharmaceuticals NY LC, Glenmark Pharmaceuticals and Msn Laboratories Private Limited. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Teriflunomide market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Tablets
- Powder
- Immunosuppression
- Cancer Treatment
- Sanofi Aventis
- Genzyme Corporation
- Amneal Pharmaceuticals NY LC
- Glenmark Pharmaceuticals
- Msn Laboratories Private Limited
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Teriflunomide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Teriflunomide, with revenue, gross margin and global market share of Teriflunomide from 2018 to 2023.
Chapter 3, the Teriflunomide competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Teriflunomide market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Teriflunomide.
Chapter 13, to describe Teriflunomide research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Teriflunomide
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Teriflunomide by Type
1.3.1 Overview: Global Teriflunomide Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Teriflunomide Consumption Value Market Share by Type in 2022
1.3.3 Tablets
1.3.4 Powder
1.4 Global Teriflunomide Market by Application
1.4.1 Overview: Global Teriflunomide Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunosuppression
1.4.3 Cancer Treatment
1.5 Global Teriflunomide Market Size & Forecast
1.6 Global Teriflunomide Market Size and Forecast by Region
1.6.1 Global Teriflunomide Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Teriflunomide Market Size by Region, (2018-2029)
1.6.3 North America Teriflunomide Market Size and Prospect (2018-2029)
1.6.4 Europe Teriflunomide Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Teriflunomide Market Size and Prospect (2018-2029)
1.6.6 South America Teriflunomide Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Teriflunomide Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Sanofi Aventis
2.1.1 Sanofi Aventis Details
2.1.2 Sanofi Aventis Major Business
2.1.3 Sanofi Aventis Teriflunomide Product and Solutions
2.1.4 Sanofi Aventis Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Aventis Recent Developments and Future Plans
2.2 Genzyme Corporation
2.2.1 Genzyme Corporation Details
2.2.2 Genzyme Corporation Major Business
2.2.3 Genzyme Corporation Teriflunomide Product and Solutions
2.2.4 Genzyme Corporation Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Genzyme Corporation Recent Developments and Future Plans
2.3 Amneal Pharmaceuticals NY LC
2.3.1 Amneal Pharmaceuticals NY LC Details
2.3.2 Amneal Pharmaceuticals NY LC Major Business
2.3.3 Amneal Pharmaceuticals NY LC Teriflunomide Product and Solutions
2.3.4 Amneal Pharmaceuticals NY LC Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Amneal Pharmaceuticals NY LC Recent Developments and Future Plans
2.4 Glenmark Pharmaceuticals
2.4.1 Glenmark Pharmaceuticals Details
2.4.2 Glenmark Pharmaceuticals Major Business
2.4.3 Glenmark Pharmaceuticals Teriflunomide Product and Solutions
2.4.4 Glenmark Pharmaceuticals Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
2.5 Msn Laboratories Private Limited
2.5.1 Msn Laboratories Private Limited Details
2.5.2 Msn Laboratories Private Limited Major Business
2.5.3 Msn Laboratories Private Limited Teriflunomide Product and Solutions
2.5.4 Msn Laboratories Private Limited Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Msn Laboratories Private Limited Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Teriflunomide Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Teriflunomide by Company Revenue
3.2.2 Top 3 Teriflunomide Players Market Share in 2022
3.2.3 Top 6 Teriflunomide Players Market Share in 2022
3.3 Teriflunomide Market: Overall Company Footprint Analysis
3.3.1 Teriflunomide Market: Region Footprint
3.3.2 Teriflunomide Market: Company Product Type Footprint
3.3.3 Teriflunomide Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Teriflunomide Consumption Value and Market Share by Type (2018-2023)
4.2 Global Teriflunomide Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Teriflunomide Consumption Value Market Share by Application (2018-2023)
5.2 Global Teriflunomide Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Teriflunomide Consumption Value by Type (2018-2029)
6.2 North America Teriflunomide Consumption Value by Application (2018-2029)
6.3 North America Teriflunomide Market Size by Country
6.3.1 North America Teriflunomide Consumption Value by Country (2018-2029)
6.3.2 United States Teriflunomide Market Size and Forecast (2018-2029)
6.3.3 Canada Teriflunomide Market Size and Forecast (2018-2029)
6.3.4 Mexico Teriflunomide Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Teriflunomide Consumption Value by Type (2018-2029)
7.2 Europe Teriflunomide Consumption Value by Application (2018-2029)
7.3 Europe Teriflunomide Market Size by Country
7.3.1 Europe Teriflunomide Consumption Value by Country (2018-2029)
7.3.2 Germany Teriflunomide Market Size and Forecast (2018-2029)
7.3.3 France Teriflunomide Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Teriflunomide Market Size and Forecast (2018-2029)
7.3.5 Russia Teriflunomide Market Size and Forecast (2018-2029)
7.3.6 Italy Teriflunomide Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Teriflunomide Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Teriflunomide Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Teriflunomide Market Size by Region
8.3.1 Asia-Pacific Teriflunomide Consumption Value by Region (2018-2029)
8.3.2 China Teriflunomide Market Size and Forecast (2018-2029)
8.3.3 Japan Teriflunomide Market Size and Forecast (2018-2029)
8.3.4 South Korea Teriflunomide Market Size and Forecast (2018-2029)
8.3.5 India Teriflunomide Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Teriflunomide Market Size and Forecast (2018-2029)
8.3.7 Australia Teriflunomide Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Teriflunomide Consumption Value by Type (2018-2029)
9.2 South America Teriflunomide Consumption Value by Application (2018-2029)
9.3 South America Teriflunomide Market Size by Country
9.3.1 South America Teriflunomide Consumption Value by Country (2018-2029)
9.3.2 Brazil Teriflunomide Market Size and Forecast (2018-2029)
9.3.3 Argentina Teriflunomide Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Teriflunomide Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Teriflunomide Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Teriflunomide Market Size by Country
10.3.1 Middle East & Africa Teriflunomide Consumption Value by Country (2018-2029)
10.3.2 Turkey Teriflunomide Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Teriflunomide Market Size and Forecast (2018-2029)
10.3.4 UAE Teriflunomide Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Teriflunomide Market Drivers
11.2 Teriflunomide Market Restraints
11.3 Teriflunomide Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Teriflunomide Industry Chain
12.2 Teriflunomide Upstream Analysis
12.3 Teriflunomide Midstream Analysis
12.4 Teriflunomide Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Teriflunomide
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Teriflunomide by Type
1.3.1 Overview: Global Teriflunomide Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Teriflunomide Consumption Value Market Share by Type in 2022
1.3.3 Tablets
1.3.4 Powder
1.4 Global Teriflunomide Market by Application
1.4.1 Overview: Global Teriflunomide Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunosuppression
1.4.3 Cancer Treatment
1.5 Global Teriflunomide Market Size & Forecast
1.6 Global Teriflunomide Market Size and Forecast by Region
1.6.1 Global Teriflunomide Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Teriflunomide Market Size by Region, (2018-2029)
1.6.3 North America Teriflunomide Market Size and Prospect (2018-2029)
1.6.4 Europe Teriflunomide Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Teriflunomide Market Size and Prospect (2018-2029)
1.6.6 South America Teriflunomide Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Teriflunomide Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Sanofi Aventis
2.1.1 Sanofi Aventis Details
2.1.2 Sanofi Aventis Major Business
2.1.3 Sanofi Aventis Teriflunomide Product and Solutions
2.1.4 Sanofi Aventis Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Aventis Recent Developments and Future Plans
2.2 Genzyme Corporation
2.2.1 Genzyme Corporation Details
2.2.2 Genzyme Corporation Major Business
2.2.3 Genzyme Corporation Teriflunomide Product and Solutions
2.2.4 Genzyme Corporation Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Genzyme Corporation Recent Developments and Future Plans
2.3 Amneal Pharmaceuticals NY LC
2.3.1 Amneal Pharmaceuticals NY LC Details
2.3.2 Amneal Pharmaceuticals NY LC Major Business
2.3.3 Amneal Pharmaceuticals NY LC Teriflunomide Product and Solutions
2.3.4 Amneal Pharmaceuticals NY LC Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Amneal Pharmaceuticals NY LC Recent Developments and Future Plans
2.4 Glenmark Pharmaceuticals
2.4.1 Glenmark Pharmaceuticals Details
2.4.2 Glenmark Pharmaceuticals Major Business
2.4.3 Glenmark Pharmaceuticals Teriflunomide Product and Solutions
2.4.4 Glenmark Pharmaceuticals Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
2.5 Msn Laboratories Private Limited
2.5.1 Msn Laboratories Private Limited Details
2.5.2 Msn Laboratories Private Limited Major Business
2.5.3 Msn Laboratories Private Limited Teriflunomide Product and Solutions
2.5.4 Msn Laboratories Private Limited Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Msn Laboratories Private Limited Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Teriflunomide Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Teriflunomide by Company Revenue
3.2.2 Top 3 Teriflunomide Players Market Share in 2022
3.2.3 Top 6 Teriflunomide Players Market Share in 2022
3.3 Teriflunomide Market: Overall Company Footprint Analysis
3.3.1 Teriflunomide Market: Region Footprint
3.3.2 Teriflunomide Market: Company Product Type Footprint
3.3.3 Teriflunomide Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Teriflunomide Consumption Value and Market Share by Type (2018-2023)
4.2 Global Teriflunomide Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Teriflunomide Consumption Value Market Share by Application (2018-2023)
5.2 Global Teriflunomide Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Teriflunomide Consumption Value by Type (2018-2029)
6.2 North America Teriflunomide Consumption Value by Application (2018-2029)
6.3 North America Teriflunomide Market Size by Country
6.3.1 North America Teriflunomide Consumption Value by Country (2018-2029)
6.3.2 United States Teriflunomide Market Size and Forecast (2018-2029)
6.3.3 Canada Teriflunomide Market Size and Forecast (2018-2029)
6.3.4 Mexico Teriflunomide Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Teriflunomide Consumption Value by Type (2018-2029)
7.2 Europe Teriflunomide Consumption Value by Application (2018-2029)
7.3 Europe Teriflunomide Market Size by Country
7.3.1 Europe Teriflunomide Consumption Value by Country (2018-2029)
7.3.2 Germany Teriflunomide Market Size and Forecast (2018-2029)
7.3.3 France Teriflunomide Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Teriflunomide Market Size and Forecast (2018-2029)
7.3.5 Russia Teriflunomide Market Size and Forecast (2018-2029)
7.3.6 Italy Teriflunomide Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Teriflunomide Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Teriflunomide Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Teriflunomide Market Size by Region
8.3.1 Asia-Pacific Teriflunomide Consumption Value by Region (2018-2029)
8.3.2 China Teriflunomide Market Size and Forecast (2018-2029)
8.3.3 Japan Teriflunomide Market Size and Forecast (2018-2029)
8.3.4 South Korea Teriflunomide Market Size and Forecast (2018-2029)
8.3.5 India Teriflunomide Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Teriflunomide Market Size and Forecast (2018-2029)
8.3.7 Australia Teriflunomide Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Teriflunomide Consumption Value by Type (2018-2029)
9.2 South America Teriflunomide Consumption Value by Application (2018-2029)
9.3 South America Teriflunomide Market Size by Country
9.3.1 South America Teriflunomide Consumption Value by Country (2018-2029)
9.3.2 Brazil Teriflunomide Market Size and Forecast (2018-2029)
9.3.3 Argentina Teriflunomide Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Teriflunomide Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Teriflunomide Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Teriflunomide Market Size by Country
10.3.1 Middle East & Africa Teriflunomide Consumption Value by Country (2018-2029)
10.3.2 Turkey Teriflunomide Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Teriflunomide Market Size and Forecast (2018-2029)
10.3.4 UAE Teriflunomide Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Teriflunomide Market Drivers
11.2 Teriflunomide Market Restraints
11.3 Teriflunomide Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Teriflunomide Industry Chain
12.2 Teriflunomide Upstream Analysis
12.3 Teriflunomide Midstream Analysis
12.4 Teriflunomide Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Teriflunomide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Teriflunomide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Teriflunomide Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Teriflunomide Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Sanofi Aventis Company Information, Head Office, and Major Competitors
Table 6. Sanofi Aventis Major Business
Table 7. Sanofi Aventis Teriflunomide Product and Solutions
Table 8. Sanofi Aventis Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Sanofi Aventis Recent Developments and Future Plans
Table 10. Genzyme Corporation Company Information, Head Office, and Major Competitors
Table 11. Genzyme Corporation Major Business
Table 12. Genzyme Corporation Teriflunomide Product and Solutions
Table 13. Genzyme Corporation Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Genzyme Corporation Recent Developments and Future Plans
Table 15. Amneal Pharmaceuticals NY LC Company Information, Head Office, and Major Competitors
Table 16. Amneal Pharmaceuticals NY LC Major Business
Table 17. Amneal Pharmaceuticals NY LC Teriflunomide Product and Solutions
Table 18. Amneal Pharmaceuticals NY LC Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Amneal Pharmaceuticals NY LC Recent Developments and Future Plans
Table 20. Glenmark Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Glenmark Pharmaceuticals Major Business
Table 22. Glenmark Pharmaceuticals Teriflunomide Product and Solutions
Table 23. Glenmark Pharmaceuticals Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Glenmark Pharmaceuticals Recent Developments and Future Plans
Table 25. Msn Laboratories Private Limited Company Information, Head Office, and Major Competitors
Table 26. Msn Laboratories Private Limited Major Business
Table 27. Msn Laboratories Private Limited Teriflunomide Product and Solutions
Table 28. Msn Laboratories Private Limited Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Msn Laboratories Private Limited Recent Developments and Future Plans
Table 30. Global Teriflunomide Revenue (USD Million) by Players (2018-2023)
Table 31. Global Teriflunomide Revenue Share by Players (2018-2023)
Table 32. Breakdown of Teriflunomide by Company Type (Tier 1, Tier 2, and Tier 3)
Table 33. Market Position of Players in Teriflunomide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 34. Head Office of Key Teriflunomide Players
Table 35. Teriflunomide Market: Company Product Type Footprint
Table 36. Teriflunomide Market: Company Product Application Footprint
Table 37. Teriflunomide New Market Entrants and Barriers to Market Entry
Table 38. Teriflunomide Mergers, Acquisition, Agreements, and Collaborations
Table 39. Global Teriflunomide Consumption Value (USD Million) by Type (2018-2023)
Table 40. Global Teriflunomide Consumption Value Share by Type (2018-2023)
Table 41. Global Teriflunomide Consumption Value Forecast by Type (2024-2029)
Table 42. Global Teriflunomide Consumption Value by Application (2018-2023)
Table 43. Global Teriflunomide Consumption Value Forecast by Application (2024-2029)
Table 44. North America Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 45. North America Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 46. North America Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 47. North America Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 48. North America Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 49. North America Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 50. Europe Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Europe Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Europe Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 53. Europe Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 54. Europe Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 55. Europe Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 56. Asia-Pacific Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 57. Asia-Pacific Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 58. Asia-Pacific Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 59. Asia-Pacific Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 60. Asia-Pacific Teriflunomide Consumption Value by Region (2018-2023) & (USD Million)
Table 61. Asia-Pacific Teriflunomide Consumption Value by Region (2024-2029) & (USD Million)
Table 62. South America Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 63. South America Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 64. South America Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 65. South America Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 66. South America Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 67. South America Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Middle East & Africa Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 69. Middle East & Africa Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 70. Middle East & Africa Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 71. Middle East & Africa Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 72. Middle East & Africa Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 73. Middle East & Africa Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 74. Teriflunomide Raw Material
Table 75. Key Suppliers of Teriflunomide Raw Materials
Table 1. Global Teriflunomide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Teriflunomide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Teriflunomide Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Teriflunomide Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Sanofi Aventis Company Information, Head Office, and Major Competitors
Table 6. Sanofi Aventis Major Business
Table 7. Sanofi Aventis Teriflunomide Product and Solutions
Table 8. Sanofi Aventis Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Sanofi Aventis Recent Developments and Future Plans
Table 10. Genzyme Corporation Company Information, Head Office, and Major Competitors
Table 11. Genzyme Corporation Major Business
Table 12. Genzyme Corporation Teriflunomide Product and Solutions
Table 13. Genzyme Corporation Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Genzyme Corporation Recent Developments and Future Plans
Table 15. Amneal Pharmaceuticals NY LC Company Information, Head Office, and Major Competitors
Table 16. Amneal Pharmaceuticals NY LC Major Business
Table 17. Amneal Pharmaceuticals NY LC Teriflunomide Product and Solutions
Table 18. Amneal Pharmaceuticals NY LC Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Amneal Pharmaceuticals NY LC Recent Developments and Future Plans
Table 20. Glenmark Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Glenmark Pharmaceuticals Major Business
Table 22. Glenmark Pharmaceuticals Teriflunomide Product and Solutions
Table 23. Glenmark Pharmaceuticals Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Glenmark Pharmaceuticals Recent Developments and Future Plans
Table 25. Msn Laboratories Private Limited Company Information, Head Office, and Major Competitors
Table 26. Msn Laboratories Private Limited Major Business
Table 27. Msn Laboratories Private Limited Teriflunomide Product and Solutions
Table 28. Msn Laboratories Private Limited Teriflunomide Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Msn Laboratories Private Limited Recent Developments and Future Plans
Table 30. Global Teriflunomide Revenue (USD Million) by Players (2018-2023)
Table 31. Global Teriflunomide Revenue Share by Players (2018-2023)
Table 32. Breakdown of Teriflunomide by Company Type (Tier 1, Tier 2, and Tier 3)
Table 33. Market Position of Players in Teriflunomide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 34. Head Office of Key Teriflunomide Players
Table 35. Teriflunomide Market: Company Product Type Footprint
Table 36. Teriflunomide Market: Company Product Application Footprint
Table 37. Teriflunomide New Market Entrants and Barriers to Market Entry
Table 38. Teriflunomide Mergers, Acquisition, Agreements, and Collaborations
Table 39. Global Teriflunomide Consumption Value (USD Million) by Type (2018-2023)
Table 40. Global Teriflunomide Consumption Value Share by Type (2018-2023)
Table 41. Global Teriflunomide Consumption Value Forecast by Type (2024-2029)
Table 42. Global Teriflunomide Consumption Value by Application (2018-2023)
Table 43. Global Teriflunomide Consumption Value Forecast by Application (2024-2029)
Table 44. North America Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 45. North America Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 46. North America Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 47. North America Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 48. North America Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 49. North America Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 50. Europe Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Europe Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Europe Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 53. Europe Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 54. Europe Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 55. Europe Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 56. Asia-Pacific Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 57. Asia-Pacific Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 58. Asia-Pacific Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 59. Asia-Pacific Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 60. Asia-Pacific Teriflunomide Consumption Value by Region (2018-2023) & (USD Million)
Table 61. Asia-Pacific Teriflunomide Consumption Value by Region (2024-2029) & (USD Million)
Table 62. South America Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 63. South America Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 64. South America Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 65. South America Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 66. South America Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 67. South America Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Middle East & Africa Teriflunomide Consumption Value by Type (2018-2023) & (USD Million)
Table 69. Middle East & Africa Teriflunomide Consumption Value by Type (2024-2029) & (USD Million)
Table 70. Middle East & Africa Teriflunomide Consumption Value by Application (2018-2023) & (USD Million)
Table 71. Middle East & Africa Teriflunomide Consumption Value by Application (2024-2029) & (USD Million)
Table 72. Middle East & Africa Teriflunomide Consumption Value by Country (2018-2023) & (USD Million)
Table 73. Middle East & Africa Teriflunomide Consumption Value by Country (2024-2029) & (USD Million)
Table 74. Teriflunomide Raw Material
Table 75. Key Suppliers of Teriflunomide Raw Materials
LIST OF FIGURES
Figure 1. Teriflunomide Picture
Figure 2. Global Teriflunomide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Teriflunomide Consumption Value Market Share by Type in 2022
Figure 4. Tablets
Figure 5. Powder
Figure 6. Global Teriflunomide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Teriflunomide Consumption Value Market Share by Application in 2022
Figure 8. Immunosuppression Picture
Figure 9. Cancer Treatment Picture
Figure 10. Global Teriflunomide Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Teriflunomide Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Teriflunomide Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Teriflunomide Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Teriflunomide Consumption Value Market Share by Region in 2022
Figure 15. North America Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Teriflunomide Revenue Share by Players in 2022
Figure 21. Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Teriflunomide Market Share in 2022
Figure 23. Global Top 6 Players Teriflunomide Market Share in 2022
Figure 24. Global Teriflunomide Consumption Value Share by Type (2018-2023)
Figure 25. Global Teriflunomide Market Share Forecast by Type (2024-2029)
Figure 26. Global Teriflunomide Consumption Value Share by Application (2018-2023)
Figure 27. Global Teriflunomide Market Share Forecast by Application (2024-2029)
Figure 28. North America Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 38. France Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Teriflunomide Consumption Value Market Share by Region (2018-2029)
Figure 45. China Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 48. India Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 62. Teriflunomide Market Drivers
Figure 63. Teriflunomide Market Restraints
Figure 64. Teriflunomide Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Teriflunomide in 2022
Figure 67. Manufacturing Process Analysis of Teriflunomide
Figure 68. Teriflunomide Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Teriflunomide Picture
Figure 2. Global Teriflunomide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Teriflunomide Consumption Value Market Share by Type in 2022
Figure 4. Tablets
Figure 5. Powder
Figure 6. Global Teriflunomide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Teriflunomide Consumption Value Market Share by Application in 2022
Figure 8. Immunosuppression Picture
Figure 9. Cancer Treatment Picture
Figure 10. Global Teriflunomide Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Teriflunomide Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Teriflunomide Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Teriflunomide Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Teriflunomide Consumption Value Market Share by Region in 2022
Figure 15. North America Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Teriflunomide Revenue Share by Players in 2022
Figure 21. Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Teriflunomide Market Share in 2022
Figure 23. Global Top 6 Players Teriflunomide Market Share in 2022
Figure 24. Global Teriflunomide Consumption Value Share by Type (2018-2023)
Figure 25. Global Teriflunomide Market Share Forecast by Type (2024-2029)
Figure 26. Global Teriflunomide Consumption Value Share by Application (2018-2023)
Figure 27. Global Teriflunomide Market Share Forecast by Application (2024-2029)
Figure 28. North America Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 38. France Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Teriflunomide Consumption Value Market Share by Region (2018-2029)
Figure 45. China Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 48. India Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Teriflunomide Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Teriflunomide Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Teriflunomide Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Teriflunomide Consumption Value (2018-2029) & (USD Million)
Figure 62. Teriflunomide Market Drivers
Figure 63. Teriflunomide Market Restraints
Figure 64. Teriflunomide Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Teriflunomide in 2022
Figure 67. Manufacturing Process Analysis of Teriflunomide
Figure 68. Teriflunomide Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
